Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.680
-0.161 (-4.19%)
At close: Apr 21, 2025, 4:00 PM
3.430
-0.250 (-6.79%)
After-hours: Apr 21, 2025, 7:36 PM EDT
Biomerica Employees
Biomerica had 64 employees as of May 31, 2024. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$88,719
Profits / Employee
-$75,781
Market Cap
9.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
BMRA News
- 4 days ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - GlobeNewsWire
- 5 days ago - Biomerica Announces Reverse Stock Split - GlobeNewsWire
- 7 weeks ago - Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - GlobeNewsWire
- 2 months ago - Biomerica's inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal - GlobeNewsWire
- 3 months ago - Biomerica Stock Trades 200% Higher After Prostate Screening Test Receives Approval - Benzinga
- 3 months ago - United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer - GlobeNewsWire
- 3 months ago - Biomerica Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 months ago - Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - GlobeNewsWire